Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'hg6 64 1'

Search results for: 'hg6 64 1'

Items 21-30 of 42

Page
per page
  1. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    Target: PARP
    Summary: PARP-1/PARP-2 inhibitor
      ≥31.7 mg/mL
  2. SP2509
    B4894 SP2509
    Target: Histone Demethylases
    Summary: Demethylase 1 (LSD1) antagonist, novel Lysine-specific
      insoluble in H2O; insoluble in EtOH; ≥19.45 mg/mL
  3. XAV-939
    A1877 XAV-939
     1 Citation
    Target: TNKS
    Summary: Tankyrase 1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
  4. BMS-345541(free base)
    B4655 BMS-345541(free base)
    Summary: IKK-1/IKK-2 inhibitor,potent and selective
      insoluble in H2O; ≥70 mg/mL
  5. Reversine
    A3760 Reversine
    Target: Aurora Kinases
    Summary: A3 adenosine receptor antagonist,ARK-1/-2/-3 inhibitor
      insoluble in H2O; ≥19.65 mg/mL
  6. BMS-911543
    A4152 BMS-911543
    Target: JAK
    Summary: JAK2 inhibitor,selective small molecule
      ≥43.3 mg/mL
  7. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  8. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT inhibitor and p53 activator
      ≥22.75 mg/mL
  9. AZD2461
    A4164 AZD2461
    Target: PARP
    Summary: Novel PARP inhibitor
      insoluble in H2O; ≥16.35 mg/mL
  10. SMI-4a
    A4193 SMI-4a
    Target: Pim
    Summary: Potent Pim inhibitor
      insoluble in H2O; ≥13.65 mg/mL

Items 21-30 of 42

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 2item
  2. Aurora Kinase 3item
  3. HDAC 11item
  4. Histone Acetyltransferases 1 item
  5. Histone Demethylases 1 item
  6. Histone Methyltransferase 2item
  7. HIF 3item
  8. JAK 7item
  9. PARP 6item
  10. Pim 1 item
  11. Protein Ser/Thr Phosphatases 2item
  12. Sirtuin 3item
Specificity
  1. Selective 28item
Reversibility
  1. Reversible 1 item
  2. Irreversible 1 item
Target
  1. Histone Deacetylases (HDACs) 10item
  2. Aurora Kinases 3item
  3. MDM2 1 item
  4. Bromodomains 2item
  5. FLT3 2item
  6. RET 1 item
  7. DOT1L 1 item
  8. Pim 1 item
  9. Sir2-like Family Deacetylases (Sirtuins) 3item
  10. PP1 1 item
  11. PP2A 1 item
  12. Src 1 item
  13. STAT 1 item
  14. Hypoxia Inducible Factors (HIFs) 1 item
  15. JAK 7item
  16. p300 1 item
  17. TNKS 1 item
  18. Topoisomerases 1 item
  19. DNA Methyltransferases 1 item
  20. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  21. PARP 5item
  22. phosphatases 1 item
  23. Histone Demethylases 1 item
  24. MNK 1 item
  25. Protein Arginine Methyltransferases 1 item
  26. PP4 1 item
  27. c-RET 1 item
  28. VEGFR3/FLT4 1 item
  29. NTRK1/TRKA 1 item
  30. CSF-1R/c-Fms 1 item
  31. p53 2item
  32. Trx 1 item
  33. p21 1 item
  34. 5-HT 1 item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Breast Cancer 4item
  3. Cancer 26item
  4. Cervical Cancer 1 item
  5. Colon Cancer 3item
  6. Colon Carcinoma 1 item
  7. Colorectal Cancer 1 item
  8. Epilepsy 1 item
  9. Glioma 1 item
  10. Hepatic Cancer 1 item
  11. Hepatocellular Carcinoma 1 item
  12. Inflammatory Diseases 1 item
  13. Leukemia 2item
  14. Lung Cancer 1 item
  15. Lymphoma 1 item
  16. Melanoma 1 item
  17. Mixed Lineage Leukemia 1 item
  18. Multiple Myeloma 2item
  19. Myelofibrosis 1 item
  20. Non-small Cell Lung Cancer 2item
  21. Ovarian Cancer 3item
  22. Pancreatic Cancer 2item
  23. Prostate Cancer 4item
  24. Renal Cell Carcinoma 1 item
  25. Rheumatoid Arthritis 1 item